Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription elongation factor B (SIII), polypeptide 1 pseudogene
- Molecular classification
- Pseudogene
01
Overview
The transcription elongation factor B (SIII), polypeptide 1 pseudogene (ENSG00000224302, AL500527.1) is a DNA sequence in the human genome that closely resembles the functional transcription elongation factor B (SIII), polypeptide 1 gene, but is incapable of encoding a functional protein. Pseudogenes like this one typically originate via duplication or retrotransposition of an ancestral functional gene, followed by the accumulation of disabling mutations. While some pseudogenes across the genome may be transcribed and exert regulatory effects (such as producing non-coding RNAs or modulating parental gene activity), there is currently no evidence that this specific pseudogene (ENSG00000224302) has any functional activity or relevance as a drug target or disease biomarker.
- Other names
- AL500527.1
02
Biological functions
Most pseudogenes lack functional biological rolesNo evidence for ENSG00000224302 having regulatory RNA function
03
Disease associations
None establishedPseudogenes generally do not have direct roles in disease
04
Safety considerations
None specific to this locusPseudogenes as a class are not associated with therapeutic safety concernsMay complicate genetic assays due to sequence similarity (e.g., PCR bias)
Beyond the preview
Go deeper on Transcription elongation factor B (SIII), polypeptide 1 pseudogene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Transcription elongation factor B (SIII), polypeptide 1 pseudogene.